Session 5

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France

<  back to Program at a glance
<  back to all the scientific sessions

Wednesday, April 24, 11:00 am – 12:30 pm
Auditorium Kagame​

Chairs: Wayne Phillips (Australia) – Dagmar Kollmann (Austria) – George Triadafilopoulos (USA) – Kenneth J. Vega (USA) – Bruno Zilberstein (Brazil)

1. Why is esophageal cancer on the rise? – David Wang (USA)
    
2. Personal reflections on anti-reflux surgery: 250 patients & 20 years of follow-up – Bruno Zilberstein (Brazil)
    
3. Debates: point/counterpoint 

• a) Should irregular z-lines be routinely biopsied?
• Pro – William Ravich (USA)
• Con – Nielsen Fernandez-Becker (USA)
• b) Should non-dysplastic Barrett’s esophagus patients be offered ablation?
• Pro – John O. Clarke (USA)
• Con – Allon Kahn (USA)
• c) Should all patients with Barrett’s esophagus be treated with high-dose PPI therapy and/or aspirin?
• Pro – Mark R. Fox (Switzerland)
• Con – Margaret Zhou (USA)
• d) Should all patients with nodular Barrett’s esophagus be treated with ESD or is EMR OK?
• Pro – Shai Friedland (USA)
• Con – Bryan Sauer (USA)
• e) Should all patients with Barrett’s esophagus be offered an anti-reflux operation & if so, which one?
• Pro – Valter Felix (Brazil)
• Con – Salih Samo (USA)